P21 is a synthetic CNTF-derived tetrapeptide carrying a C-terminal adamantylglycine. It is studied for its effect on endogenous CNTF and BDNF signalling in hippocampal neurogenesis research, and NuVion stocks it in Australia as a 10mg lyophilised vial.
- Ac-DGGLAG-NH2, a DGGL tetrapeptide with a C-terminal adamantylglycine
- Derived from the CNTF active fragment (residues 148 to 151)
- Studied for its effect on endogenous CNTF and BDNF signalling
- Supplied lyophilised, purity by RP-HPLC and identity by mass spectrometry
P21 structure and research use
P21 is built on four residues of ciliary neurotrophic factor (CNTF), Asp-Gly-Gly-Leu, taken from positions 148 to 151. An adamantylglycine is added at the C-terminus, giving Ac-DGGLAG-NH2. The sequence was identified by epitope mapping of Cerebrolysin peptides, and in the research literature it also appears as P021. In the laboratory it is used in hippocampal neurogenesis research models for work on CNTF and BDNF signalling.
P21 research applications
- BDNF and CNTF measured in conditioned medium by ELISA and as transcript by qPCR in cultured neurons and glia
- Western blot for phosphorylated TrkB, Akt and ERK, with receptor-blocking controls to test indirect action
- CREB phosphorylation at serine 133 and CRE reporter assays linking kinase activation to transcription
- Neurite outgrowth morphometry in primary neuronal or neuronal cell line culture, scoring neurite length and branch number
P21 key facts
| Type | Synthetic modified tetrapeptide |
|---|---|
| Core amino acid count | 4 (Asp-Gly-Gly-Leu), plus a C-terminal adamantylglycine |
| Sequence | Ac-DGGLAG-NH2, read as acetyl-Asp-Gly-Gly-Leu-adamantylglycine-amide. The AG is a single modified residue, not Ala-Gly. |
| Parent protein region | CNTF active region, residues 148 to 151 |
| Modification | Adamantane cage on the C-terminal glycine, plus N-terminal acetyl and C-terminal amide |
| Origin | Epitope mapping of Cerebrolysin peptide constituents |
| Also known as | P021, Peptide 021 |
| Vial size | 10mg, lyophilised |
| Purity | 99.44% by RP-HPLC, Janoshik Analytical |
| Analysed | 11 February 2026 |
Research profile: P21: structure, mechanism and research use
Independent test: a sample of this product was analysed by Janoshik Analytical on 11 February 2026, purity 99.44% by RP-HPLC. The certificate is shown in the lab band on this page.





